On Dec. 2, 2020, Roche announced that its Elecsysﾮ Anti-SARS-CoV-2 S antibody test had received Emergency Use Authorization (EUA) from the FDA. The serology (blood) test can be used to measure the level of antibodies in people who have been exposed to the SARS-CoV-2 virus.

The EUA in the U.S. followed the launch of the Elecsysﾮ Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark announced on Sept 18.